litlas
ログインアカウント作成

Geoffrey R. Oxnard

2004–2025 年に発表

160
論文数
25,264
被引用数
76
h 指数
155
i10 指数

被引用数

Geoffrey R. Oxnard の年別被引用数1971 年: 被引用 1 件1993 年: 被引用 1 件1999 年: 被引用 1 件2004 年: 被引用 3 件2005 年: 被引用 1 件2006 年: 被引用 2 件2007 年: 被引用 2 件2008 年: 被引用 1 件2010 年: 被引用 3 件2011 年: 被引用 34 件2012 年: 被引用 94 件2013 年: 被引用 150 件2014 年: 被引用 114 件2015 年: 被引用 208 件2016 年: 被引用 362 件2017 年: 被引用 364 件2018 年: 被引用 417 件2019 年: 被引用 1,146 件2020 年: 被引用 1,335 件2021 年: 被引用 1,480 件2022 年: 被引用 1,242 件2023 年: 被引用 1,041 件2024 年: 被引用 1,499 件2025 年: 被引用 819 件2026 年: 被引用 22 件1972〜1992 年は被引用が無いため表示していません1994〜1998 年は被引用が無いため表示していません2000〜2003 年は被引用が無いため表示していません2009 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,183 件、この内訳の 25.9%中国: 引用元論文 1,592 件、この内訳の 12.9%イタリア: 引用元論文 708 件、この内訳の 5.8%イギリス: 引用元論文 663 件、この内訳の 5.4%日本: 引用元論文 586 件、この内訳の 4.8%フランス: 引用元論文 528 件、この内訳の 4.3%ドイツ: 引用元論文 486 件、この内訳の 4%スペイン: 引用元論文 465 件、この内訳の 3.8%カナダ: 引用元論文 384 件、この内訳の 3.1%韓国: 引用元論文 363 件、この内訳の 2.9%オランダ: 引用元論文 319 件、この内訳の 2.6%オーストラリア: 引用元論文 275 件、この内訳の 2.2%
0%25.9%その他 22.3%

機関

分野

  • Medicine62.3%
  • Biochemistry, Genetics and Molecular Biology33.3%
  • Immunology and Microbiology0.9%
  • Computer Science0.8%
  • Chemistry0.7%
  • Engineering0.6%
  • その他1.4%

トピック

  • Lung Cancer Treatments and Mutations15.5%
  • Cancer Genomics and Diagnostics12.2%
  • Lung Cancer Research Studies5.5%
  • Cancer Immunotherapy and Biomarkers4.3%
  • Lung Cancer Diagnosis and Treatment3.9%
  • Colorectal Cancer Treatments and Studies2.2%
  • その他56.4%

共著者

全論文

検索で開く
  1. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

    著者: M.C. Liu, Geoffrey R. Oxnard, Eric A. Klein, Charles Swanton, Michael V. Seiden, Minetta C. Liu, Geoffrey R. Oxnard, Eric A. Klein, David A. Smith, Donald Richards, Timothy J. Yeatman, Allen Lee Cohn, Rosanna L. Lapham, Jessica Clément, Alexander S. Parker, Mohan K. Tummala, Kristi McIntyre, Mikkael A. Sekeres, Alan H. Bryce, Robert D. Siegel, Xuezhong Wang, David Cosgrove, Nadeem R. Abu‐Rustum, Jonathan C. Trent, David D. Thiel, Carlos Becerra, Manish Agrawal, Lawrence Garbo, Jeffrey K. Giguere, Ross M. Michels, Ronald P. Harris, Stephen Richey, Timothy A. McCarthy, David Waterhouse, Fergus J. Couch, Sharon Wilks, Amy Krie, Rama Balaraman, Álvaro Restrepo, Michael W. Meshad, Kimberly Rieger‐Christ, Travis Sullivan, Christine Lee, Daniel Greenwald, William Oh, Che‐Kai Tsao, Neil Fleshner, Hagen F. Kennecke, Maged Khalil, David R. Spigel, Atisha Manhas, Brian Ulrich, P. Kovoor, Christopher Stokoe, Jay Courtright, Habte Yimer, Timothy Larson, Charles Swanton, Michael V. Seiden, Steven R. Cummings, Farnaz Absalan, Gregory E. Alexander, Brian C. Allen, Hamed Amini, Alexander M. Aravanis, Siddhartha Bagaria, Leila Bazargan, John F. Beausang, Jennifer R. Berman, Craig Betts, Alexander W. Blocker, Joerg Bredno, Robert Calef, Gordon Cann, Jeremy G. Carter, Christopher Chang, Hemanshi Chawla, Xiaoji Chen, Tom C. Chien, Daniel Civello, Konstantin Davydov, Vasiliki Demas, Konstantin Davydov, Dong Zhao, Saniya Fayzullina, Alexander P. Fields, Darya Filippova, Peter Freese, Eric T. Fung, Sante Gnerre, Samuel Gross, Meredith Halks‐Miller, Megan P. Hall, Anne‐Renee Hartman, Chenlu Hou, Earl Hubbell, Nathan Hunkapiller, Karthik A. Jagadeesh, Arash Jamshidi, Roger Jiang ほか 59 名 - Annals of Oncology 2020 被引用: 1,509

  2. Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer

    著者: Alexander Drilon, Geoffrey R. Oxnard, Daniel Shao-Weng Tan, Herbert H. Loong, Melissa L. Johnson, Justin F. Gainor, Caroline E. McCoach, Oliver Gautschi, Benjamin Besse, Byoung Chul Cho, Nir Peled, Jared Weiss, Yu-Jung Kim, Yuichiro Ohe, Makoto Nishio, Keunchil Park, Jyoti D. Patel, Takashi Seto, Tomohiro Sakamoto, Ezra Y. Rosen, Manisha H. Shah, Fabrice Barlési, Philippe A. Cassier, Lyudmila Bazhenova, Filippo de Braud, Elena Garralda, Vamsidhar Velcheti, Miyako Satouchi, Kadoaki Ohashi, Nathan A. Pennell, Karen L. Reckamp, Grace K. Dy, Jürgen Wolf, Benjamin Solomon, Gerald S. Falchook, Kevin Ebata, Michele Nguyen, Binoj C. Nair, Edward Y. Zhu, Luxi Yang, Xin Huang, Elizabeth Olek, S. Michael Rothenberg, Kōichi Goto, Vivek Subbiah - New England Journal of Medicine 2020 被引用: 836

  3. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

    著者: Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip, Byoung Chul Cho, Daniel Stetson, Brian Dougherty, Zhongwu Lai, Aleksandra Markovets, Ana Vivancos, Yanan Kuang, Dalia Ercan, Sarah E Matthews, Mireille Cantarini, J. Carl Barrett, Pasi A. Jänne, Geoffrey R. Oxnard - Nature Medicine 2015 被引用: 1,539

  4. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

    著者: Jason D. Merker, Geoffrey R. Oxnard, Carolyn C. Compton, Maximilian Diehn, Patricia A. Hurley, Alexander J. Lazar, Neal Lindeman, Christina M. Lockwood, Alex J. Rai, Richard L. Schilsky, Apostolia M. Tsimberidou, Patricia Vasalos, Brooke L. Billman, Thomas K. Oliver, Suanna S. Bruinooge, Daniel F. Hayes, Nicholas C. Turner - Archives of Pathology & Laboratory Medicine 2018 被引用: 929

  5. Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study

    著者: Zachery R. Reichert, Todd M. Morgan, Gerald Li, Emily Castellanos, Tamara Snow, Filippo Gustavo Dall’Olio, Russell W. Madison, Alexander D. Fine, Geoffrey R. Oxnard, Ryon P. Graf, Daniel G. Stover - Annals of Oncology 2022 被引用: 201

  6. Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors

    著者: Jessica Lee, Smruthy Sivakumar, Alexa B. Schrock, Russell W. Madison, David Fabrizio, Ole Gjoerup, Jeffrey S. Ross, Garrett M. Frampton, Pavel Napalkov, Meagan Montesion, Jennifer L. Schutzman, Xin Ye, Priti S. Hegde, Misako Nagasaka, Geoffrey R. Oxnard, Ethan Sokol, Sai‐Hong Ignatius Ou, Zhen Shi - npj Precision Oncology 2022 被引用: 167

  7. A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer

    著者: Zoe J. Assaf, Wei Zou, Alexander D. Fine, Mark A. Socinski, Amanda Young, Doron Lipson, Jonathan F. Freidin, Mark Kennedy, Eliana Polisecki, Makoto Nishio, David Fabrizio, Geoffrey R. Oxnard, Craig Cummings, Anja Rode, Martin Reck, Namrata S. Patil, Mark Lee, David S. Shames, Katja Schulze - Nature Medicine 2023 被引用: 139

  8. Assessment of Resistance Mechanisms and Clinical Implications in Patients WithEGFRT790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

    著者: Geoffrey R. Oxnard, Yuebi Hu, Kathryn F. Mileham, Hatim Husain, Daniel B. Costa, Philip Tracy, Nora Feeney, Lynette M. Sholl, Suzanne E. Dahlberg, Amanda J. Redig, David J. Kwiatkowski, Michael S. Rabin, Cloud P. Paweletz, Kenneth S. Thress, Pasi A. Jänne - JAMA Oncology 2018 被引用: 689

  9. MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

    著者: Mark M. Awad, Geoffrey R. Oxnard, David M. Jackman, Daniel O. Savukoski, Dimity Hall, Priyanka Shivdasani, Jennifer Heng, Suzanne E. Dahlberg, Pasi A. Jänne, Suman Verma, James G. Christensen, Peter S. Hammerman, Lynette M. Sholl - Journal of Clinical Oncology 2016 被引用: 688

  10. TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer

    著者: Geoffrey R. Oxnard, J.C.-H. Yang, Helena A. Yu, Seung‐Whan Kim, Hideo Saka, Leora Horn, Kōichi Goto, Yuichiro Ohe, Helen Mann, Kenneth S. Thress, Melanie M. Frigault, Karthick Vishwanathan, Dana Ghiorghiu, Suresh S. Ramalingam, Myung‐Ju Ahn - Annals of Oncology 2020 被引用: 444

  11. Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

    著者: Lecia V. Sequist, Ji‐Youn Han, Myung‐Ju Ahn, Byoung Chul Cho, Helena A. Yu, Sang-We Kim, James Chih‐Hsin Yang, Jong Seok Lee, Wu‐Chou Su, Dariusz M. Kowalski, Sergey Orlov, Mireille Cantarini, Remy B. Verheijen, Anders Mellemgaard, Lone H. Ottesen, Paul Frewer, Xiaoling Ou, Geoffrey R. Oxnard - The Lancet Oncology 2020 被引用: 413

  12. Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms

    著者: Hanna Tukachinsky, Russell W. Madison, Jon Chung, Ole Gjoerup, Eric A. Severson, Lucas Dennis, Bernard J. Fendler, Samantha Morley, Lei Zhong, Ryon P. Graf, Jeffrey S. Ross, Brian M. Alexander, Wassim Abida, Simon Chowdhury, Charles J. Ryan, Karim Fizazi, Tony Golsorkhi, Simon P. Watkins, Andrew D. Simmons, Andrea Loehr, Jeffrey M. Venstrom, Geoffrey R. Oxnard - Clinical Cancer Research 2021 被引用: 194

  13. False-Positive Plasma Genotyping Due to Clonal Hematopoiesis

    著者: Yuebi Hu, Bryan C. Ulrich, Julianna Supplee, Yanan Kuang, Patrick H. Lizotte, Nora Feeney, Nicolas Guibert, Mark M. Awad, Kwok‐Kin Wong, Pasi A. Jänne, Cloud P. Paweletz, Geoffrey R. Oxnard - Clinical Cancer Research 2018 被引用: 446

  14. Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer

    著者: Hiroyuki Yasuda, Eunyoung Park, Cai-Hong Yun, Natasha Sng, Antonio R. Lucena‐Araujo, Wee-Lee Yeo, Mark S. Huberman, David Cohen, Sohei Nakayama, Kota Ishioka, Norihiro Yamaguchi, Megan Hanna, Geoffrey R. Oxnard, Christopher S. Lathan, Teresa Morán, Lecia V. Sequist, Jamie E. Chaft, Gregory J. Riely, Maria E. Arcila, Ross A. Soo, Matthew Meyerson, Michael J. Eck, Susumu Kobayashi, Daniel B. Costa - Science Translational Medicine 2013 被引用: 565

  15. Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples

    著者: Hatim Husain, Dean C. Pavlick, Bernard J. Fendler, Russell W. Madison, Brennan Decker, Ole Gjoerup, Christine A. Parachoniak, Molly McLaughlin-Drubin, Rachel Erlich, Alexa B. Schrock, Garrett M. Frampton, Meghna Das Thakur, Geoffrey R. Oxnard, Hanna Tukachinsky - JCO Precision Oncology 2022 被引用: 98

  16. Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC

    著者: Gonzalo Recondo, Magda Bahcall, Liam F. Spurr, Jianwei Che, Biagio Ricciuti, Giulia C. Leonardi, Ying‐Chun Lo, Yvonne Y. Li, Giuseppe Lamberti, Tom Nguyen, Marina S.D. Milan, Deepti Venkatraman, Renato Umeton, Cloud P. Paweletz, Adem Albayrak, Andrew D. Cherniack, Kristin S. Price, Stephen R. Fairclough, Mizuki Nishino, Lynette M. Sholl, Geoffrey R. Oxnard, Pasi A. Jänne, Mark M. Awad - Clinical Cancer Research 2020 被引用: 219

  17. RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies

    著者: Benjamin Solomon, Lavinia Tan, W. Marston Linehan, Stephen Q. Wong, Sebastian Hollizeck, Kevin Ebata, Brian B. Tuch, Satoshi Yoda, Justin F. Gainor, Lecia V. Sequist, Geoffrey R. Oxnard, Oliver Gautschi, Alexander Drilon, Vivek Subbiah, Christine Khoo, Edward Y. Zhu, Michele Nguyen, Dahlia Henry, Kevin R. Condroski, Gabrielle R. Kolakowski, Eliana B Gómez, Joshua A. Ballard, Andrew T. Metcalf, James F. Blake, Sarah‐Jane Dawson, Wayne Blosser, Louis F. Stancato, Barbara J. Brandhuber, Steve Andrews, Bruce G. Robinson, S. Michael Rothenberg - Journal of Thoracic Oncology 2020 被引用: 284

  18. Institutional implementation of clinical tumor profiling on an unselected cancer population

    著者: Lynette M. Sholl, T. Khanh, Priyanka Shivdasani, Ethan Cerami, Adrian M. Dubuc, Frank C. Kuo, Elizabeth P. Garcia, Yonghui Jia, Phani K. Davineni, Ryan Abo, Trevor J. Pugh, Paul Van Hummelen, Aaron R. Thorner, Matthew D. Ducar, Alice H. Berger, Mizuki Nishino, Katherine A. Janeway, Alanna J. Church, Marian H. Harris, Lauren L. Ritterhouse, Joshua D. Campbell, Vanesa Rojas‐Rudilla, Azra H. Ligon, Shakti Ramkissoon, James M. Cleary, Ursula A. Matulonis, Geoffrey R. Oxnard, Richard C. Chao, Vanessa Tassell, James G. Christensen, William C. Hahn, Philip W. Kantoff, David J. Kwiatkowski, Bruce E. Johnson, Matthew Meyerson, Levi A. Garraway, Geoffrey I. Shapiro, Barrett J. Rollins, Neal I. Lindeman, Laura E. MacConaill - JCI Insight 2016 被引用: 448

  19. Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

    著者: Vivek Subbiah, Justin F. Gainor, Geoffrey R. Oxnard, Daniel Shao-Weng Tan, Dwight H. Owen, Byoung Chul Cho, Herbert H. Loong, Caroline E. McCoach, Jared Weiss, Yu Jung Kim, Lyudmila Bazhenova, Keunchil Park, Haruko Daga, Benjamin Besse, Oliver Gautschi, Christian Rolfo, Edward Y. Zhu, Jennifer Kherani, Xin Huang, Suhyun Kang, Alexander Drilon - Clinical Cancer Research 2021 被引用: 140

  20. Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA

    著者: Jhanelle E. Gray, Myung‐Ju Ahn, Geoffrey R. Oxnard, Frances A. Shepherd, Fumio Imamura, Ying Cheng, Isamu Okamoto, Byoung Chul Cho, Meng‐Chih Lin, Yi‐Long Wu, Margarita Majem, Oliver Gautschi, Michael Boyer, Krishna C. Bulusu, Aleksandra Markovets, J. Carl Barrett, Rachel Hodge, Astrid McKeown, Ryan J. Hartmaier, Juliann Chmielecki, Vassiliki A. Papadimitrakopoulou, Suresh S. Ramalingam - Clinical Cancer Research 2023 被引用: 60

  21. Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer

    著者: Geoffrey R. Oxnard, Kenneth S. Thress, Ryan S. Alden, Rachael Lawrance, Cloud P. Paweletz, Mireille Cantarini, James Chih‐Hsin Yang, J. Carl Barrett, Pasi A. Jänne - Journal of Clinical Oncology 2016 被引用: 843

  22. Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA

    著者: Xiaoji Chen, Dong Zhao, Earl Hubbell, Kathryn N. Kurtzman, Geoffrey R. Oxnard, Oliver Venn, Collin Melton, Christina A. Clarke, Rita Shaknovich, Ting Ma, Gerry Meixiong, Michael V. Seiden, Eric A. Klein, Eric T. Fung, Minetta C. Liu - Clinical Cancer Research 2021 被引用: 121

  23. Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

    著者: Michael L. Cheng, Eirini Pectasides, Glenn J. Hanna, Heather A. Parsons, Atish D. Choudhury, Geoffrey R. Oxnard - CA A Cancer Journal for Clinicians 2020 被引用: 208

  24. Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation

    著者: Christian Rolfo, Russell W. Madison, Lincoln W. Pasquina, Derek W. Brown, Yanmei Huang, Jason D. Hughes, Ryon P. Graf, Geoffrey R. Oxnard, Hatim Husain - Clinical Cancer Research 2024 被引用: 86